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Volume 57, Number 1 Abstracts 295Methods: During a 24-month period, 84 high-risk patients (75 men
and 8 women) underwent FEVAR using physician-modified fenestrated
Zenith endografts. Of these, 19 patients (23%; 15 men and 4 women) were
octogenarians. Technical success was defined as complete exclusion of the
aneurysm with successful catheterization and patent target arteries.
Results: Median age was 72 years (interquartile [IQR] range, 65-79
years) for the entire cohort and 83 years (IQR, 81-86 years) among
octogenarians. All octogenarians were considered unfit for open repair and
had a median Society for Vascular Surgery comorbidity score of 16 (IQR,
12-18).More octogenarians presented with symptomatic aneurysms (45% vs
10%) and severe aortoiliac occlusive disease (40% vs 25%). Their median
aneurysm size was 6.2 cm (IQR, 5.4-6.8 cm). Most aortic aneurysms in
octogenarians were suprarenal (50%); 28% were thoracoabdominal, and 32%
were juxtarenal. Endografts were customized to include 52 fenestrations/
branches (33 renal, 12 superior mesenteric, and 6 celiac arteries). Octoge-
narians were more likely to have unfavorable anatomy (42% vs 22%) because
of severe suprarenal neck angulation (16%), reverse taper neck (16%), and
circumferential thrombus at the renal arteries (11%). Three patients pre-
sented with severe preprocedural renal stenosis and two with visceral artery
stenosis. Technical success for stenting of the fenestrated/branched arteries
was 98% (51 of 52). One renal artery was lost in a patient with unfavorable
anatomy. No mesenteric arteries were lost. Median procedure time was 267
minutes (IQR, 158-339 minutes), and median fluoroscopy time was 79
minutes (IQR, 66-91 minutes). No 30-day mortality occurred. Median
hospital stay was 7 days (IQR, 6-9 days). Prolonged ileus (21%), blue toe
syndrome (11%), access vessel injury (11%), worsening renal insufficiency
(11%), pneumonia (5%), and renal artery dissection (5%) were the most
frequent complications. No periprocedural paraplegia or strokes occurred.
Conclusions: FEVAR is safe and effective in the treatment of
complex aortic aneurysms in octogenarians, even in those with unfavor-
able anatomy. Further evaluation of this technique in octogenarians is
needed to define long-term outcomes, durability of the repair and effects
on patient survival.
Impact of Uninterrupted Use of Clopidogrel on Postoperative Com-
plications After Extracavitary Vascular Surgical Procedures
Panos Kougias, Neal Barshes, George Pisimisis, Peter Lin, Briauna Lowery,
Carlos Bechara.. Baylor College of Medicine, Houston, Tex
Objectives: Patients with vascular disease commonly need a potent
antiplatelet medical regimen, whose impact on complications remains un-
clear. In this study we sought to determine the role of uninterrupted use of
clopidogrel on bleeding and perioperative complications in patients under-
going open extracavitary vascular surgical interventions.
Methods: Consecutive patients (n  872) who underwent carotid
endarterectomy, endovascular aneurysm repair, femoral and infrainguinal
reconstructions, or major amputations (n 1354 operations) were stratified
on quintiles of propensity scores calculated as their probability to continue
uninterrupted use of clopidogrel in the perioperative period. The propensity
score was calculated on the basis of operation type, demographics, and
comorbidities, including the revised cardiac risk index. Random effects
linear, logistic, and Poisson regression were used to model outcomes.
Results:There was a trend for increased incidence of hematomas in the
clopidogrel group (odds ratio [OR], 2.39; 95% confidence interval [CI],
0.99-5.8; P  .052); however, the incidence of severe bleeding that neces-
sitated take-back (OR, 0.75; 95% CI, 0.14-4.03; P  .74) and the periop-
erative mortality and cardiac complications (OR, 0.99; 95% CI, 0.49-1.72;
P .8)were similar. Furthermore, wound complications (OR, 1.14; 95%CI,
0.64-2.03; P  .65), intraoperative blood loss (coefficient, 12.8; 95% CI,
	54 to 29 mL; P  .55), intraoperative blood transfusion (coefficient,
	0.1; 95% CI,	0.3 to 0.11 units; P .4), postoperative blood transfusion
(coefficient,	 0.07; 95%CI,	0.35 to 0.2 units; P .6), and operative time
(coefficient,	10.4 minutes; 95% CI,	28.3 to 7.45 minutes; P .25) were
all comparable between the groups. The postoperative length of stay (me-
dian 4 vs 5 days; incidence rate ratios, 1.15; 95% CI, 1.04-1.27; P  .002)
and the intensive care unit length of stay (median 1 vs 2 days; incidence rate
ratios, 1.24; 95% CI, 1.03-1.5; P  .02) were longer in the clopidogrel
group. Interaction terms between age or procedure type and clopidogrel for
the above end points were all statistically nonsignificant.
Conclusions: Uninterrupted perioperative use of clopidogrel in pa-
tients undergoing extracavitary vascular operations is associated with a
marginal increase in hematoma formation and postoperative and intensive
care unit length of stay. Wound complications, cardiac complications, peri-
operative mortality, and perioperative transfusion needs are not affected by
clopidogrel administration. These findings were consistent across all age
groups and procedure types under investigation. On the basis of this data,
uninterrupted perioperative use of clopidogrel is justified in patients under-
going the operation types we examined.
T
tnitial Procedural Analysis of the Treatment of Iliac Artery Disease
ith Orbital Atherectomy
obert Botta,1 Jeffrey Indes, MD2. 1University of Connecticut School of
edicine, Farmington, Conn; 2Yale University School of Medicine, New
aven, Conn
Objectives: Atherectomy has been shown to effectively treat femoro-
opliteal disease, but very little has been reported on its usefulness in iliac
rtery disease. The objective of our study was to provide an initial evaluation
f the safety and efficacy of orbital atherectomy in treating iliac artery lesions.
Methods: This was a retrospective, multicenter study of patients
reated with orbital atherectomy between November 2009 and July 2011.
eriprocedural data were collected on an intent-to-treat basis and included
atient and lesion characteristics, procedural characteristics, results, and
omplications.
Results: A total of 85 iliac artery lesions in 79 patients (58%men; mean
ge, 70 2 years) were treated, with a median Rutherford stage of 3 (range,
-6).Most lesions were de novo (96%) with amean stenosis diameter of 86%
% (occluded in 5 [6%]) and a mean length of 45  8 mm (range, 2-200
m). Plaque morphology included lesions that were 75% calcified in 50
60%); 50% to 75% calcified in 29 (35%); 25% to 50% calcified in zero (0%);
25% calcified in one(1%); fibrotic in 4 (5%); and soft plaque in zero (0%).
rbital atherectomy achieved a mean stenosis reduction of 39%  4% with
tand-alone treatment. Angioplasty was performed in 73 patients (86%). The
ean maximum inflation pressure was 6.4  0.7 mm Hg (range, 1-12 mm
g) and achieved a mean residual stenosis of 11%  3%. Stents were placed
n 37 patients (44%). Embolic protection was not used in these procedures.
he procedural success rate was 96%. There were no deaths, and the
omplication rate was 8%. Complications included acute thrombosis in one
1%), embolism in one (1%), dissection in four (5%), and perforation in one
1%).
Conclusions: Initial assessments show orbital atherectomy to be safe
nd effective in treating peripheral arterial disease of the iliac artery. Further
tudies are necessary to determine patency, limb salvage, and cost effective-
ess of these procedures compared with other treatment modalities.
ontemporary Results of Carotid Endarterectomy (CEA) in “Normal-
isk” Patients From the Society for Vascular Surgery (SVS) Vascular
egistry
oseph J. Ricotta,MD,1David L. Gillespie,MD,2 Patrick J. Geraghty,MD,3
homas E. Brothers, MD,4 Christopher T. Kenwood, MS,5 Flora S. Siami,
PH,5 John J. Ricotta, MD,6 Rodney A. White, MD7. 1Northside Hos-
ital Heart and Vascular Institute, Atlanta, Ga; 2University of Rochester,
ochester, NY; 3WashingtonUniversity, St. Louis,Mo; 4Medical University
f South Carolina, Charleston, SC; 5New England Research Institutes, Inc,
atertown, Mass; 6Washington Hospital Center, Washington, DC; 7Har-
or UCLA, Los Angeles, Calif
Objectives: “Acceptable” complication rates after CEA are drawn from
ata that are decades old. The CREST trial demonstrated improved out-
ome after CEA but may not represent “real-world” results. Results of
arotid stenting (CAS) in “normal-risk” (NR) patients are limited. This
tudy was done to determine “real-world” contemporary results of CEA in
R patients.
Methods: The Society for Vascular Surgery Vascular (SVS) Registry
as examined to determine in-hospital and 30-day event rates for NR
ymptomatic (SX) and asymptomatic (ASX) patients undergoing CEA. NR
s defined as patients without anatomic or physiologic risk factors, as defined
y SVS Carotid Practice Guidelines. Raw data and risk-adjusted rates of
eath, stroke, and myocardial infarction (MI) were compared between the
SX and SX cohorts.
Results: There were 3977 patients (2521 ASX, 1456 SX) available for
omparison. SX had 62% men vs 57% in ASX (P  .004), and ASX had a
reater proportion of Caucasian patients (94.4%) vs 91.3% in SX (P 
0002), with a higher rate of coronary artery disease andMI (both P .001),
eripheral vascular disease (P  .001), and hypertension (P  .029). More
SX had baseline stenosis 80% by ultrasound imaging (68% vs 54% in SX,
 .0001). Ninety-eight percent of both groups were New York Heart
ssociation grade 3, and 90% were taking antiplatelet agents preopera-
ively. ASX had lower perioperative (0.8% ASX, 2.7% SX) and 30-day (1.0%
SX, 3.4% SX) stroke rates (P  .0001), which contributed to the lower
ates of composite death, stroke, and MI perioperatively (1.7% ASX, 3.6%
X; P .0003) and at 30 days (2.2% ASX vs 4.5% SX; P .0001). Raw and
isk-adjusted rates of death and MI did not differ between groups. Absolute
nd risk adjusted perioperative stroke was increased in SX (odds ratio, 2.9;
 .004).
Conclusions:Contemporary results of CEA have improved, are similar
o CREST, and are better than established norms for SX and ASX patients.
hese results should serve as a benchmark for comparing results of alterna-
ive therapies for treatment of carotid stenosis in NR patients.
